Related Experiment Video
Updated: Aug 9, 2026

12:24
A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
Published on: January 23, 2016
Relationship between chimerism and tolerance in a kidney transplantation model
Y Fuchimoto1, K Yamada, A Shimizu
1Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02129, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|May 7, 1999
Summary
Persistent donor leukocytes in organ transplant recipients do not guarantee graft acceptance. This study shows donor cell microchimerism is not required for long-term kidney allograft tolerance in swine.
Area of Science:
- Transplantation immunology
- Immunogenetics
- Organ allograft acceptance
Background:
- Donor leukocyte persistence post-transplant is linked to graft acceptance.
- The role of donor cell microchimerism in graft acceptance remains debated.
- Distinguishing active immune roles from immunosuppression consequences is key.
Purpose of the Study:
- To investigate the correlation between donor leukocyte chimerism and kidney allograft acceptance.
- To determine if persistent donor cell microchimerism is essential for maintaining transplant tolerance.
- To utilize a swine model allowing tolerance with or without immunosuppression.
Main Methods:
- SLA-identical miniature swine kidney transplantation model.
- Recipients received either a short course of cyclosporine (CyA) or no immunosuppression.
- Donor leukocyte chimerism assessed by Flow Cytometry (FACS); graft acceptance monitored by serum creatinine.
Main Results:
- Kidney transplant recipients treated with CyA achieved tolerance with detectable donor chimerism (0.2-0.7%).
- Untreated control recipients also achieved tolerance without detectable peripheral donor leukocytes beyond 1 week.
- Donor cell persistence was not observed in all tolerant recipients, indicating it's not a prerequisite.
Conclusions:
- Persistent donor cell chimerism is not a requirement for maintaining long-term organ allograft tolerance in this swine model.
- Tolerance can be established independently of sustained peripheral donor leukocyte presence.
- Findings challenge the necessity of microchimerism for graft acceptance.
Related Concept Videos
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

